Chad Oh serves as Executive at AEON Biopharma, Inc., where they oversee executive responsibilities. Since joining the company, Chad Oh has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 31, 2024 involved receiving (via award) 192,117 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Aug 31, 2024 | AEON | $0 | Award | 192,117 | $N/A | Discretionary |
Chad Oh currently holds 292,545 shares of AEON Biopharma, Inc. (AEON), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Chad Oh has been a net neutral trader of AEON stock. They have purchased $0 and sold $0 worth of shares.
Chad Oh's most recent insider trade was on Aug 31, 2024, when they sold 192,117 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted